Revlimid and Facial paralysis - a phase IV clinical study of FDA data

Summary:

Facial paralysis is reported as a side effect among people who take Revlimid (lenalidomide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Bactrim, and have Pain.

The phase IV clinical study analyzes which people have Facial paralysis when taking Revlimid. It is created by eHealthMe based on reports of 377,717 people who have side effects when taking Revlimid from the FDA, and is updated regularly.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

What is Facial paralysis?

Facial paralysis (loss of function of face muscle) is found to be associated with 662 drugs and 1,149 conditions by eHealthMe. Check the latest studies of Facial paralysis.

On Jul, 23, 2026

377,717 people reported to have side effects when taking Revlimid.
Among them, 78 people (0.02%) have Facial paralysis.

Among these 78 people:

How long have people been on Revlimid when they have Facial paralysis? *

What is the gender of people who have Facial paralysis when taking Revlimid? *

female: 59.74 %
male: 40.26 %

What is the age of people who have Facial paralysis when taking Revlimid? *

What are other drugs people take besides Revlimid? *

What are other side effects people have besides Facial paralysis? *

Thrombocytopenia (decrease of platelets in blood): 15 people, 19.23%
Anaemia (lack of blood): 12 people, 15.38%
Weight Increased: 11 people, 14.10%
High Blood Pressure: 10 people, 12.82%
Fatigue (feeling of tiredness): 10 people, 12.82%
Diarrhea: 9 people, 11.54%
Brain Abscess: 9 people, 11.54%
Weakness: 9 people, 11.54%
Weight Decreased: 8 people, 10.26%
Listeriosis (a food borne illness caused by listeria monocytogenes, bacteria found in soil and water): 8 people, 10.26%

What are the existing conditions these people have? *

Infection: 5 people, 6.41%
Pain: 5 people, 6.41%
High Blood Pressure: 4 people, 5.13%
Depression: 4 people, 5.13%
Nausea (feeling of having an urge to vomit): 2 people, 2.56%
Monoclonal Gammopathy: 2 people, 2.56%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 2.56%
Amyloidosis (a tumour within which amyloid is produced): 1 person, 1.28%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 1 person, 1.28%
Cardiac Disorder: 1 person, 1.28%

* Approximation only. Some reports may have incomplete information.

Do you take Revlimid and have Facial paralysis?

- Check whether Facial paralysis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Revlimid:

Revlimid (378,026 reports)

Browse all side effects of Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Facial paralysis:

Facial paralysis (662 drugs)

Browse all the conditions that are associated with Facial paralysis:

Facial paralysis (1,149 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.